A Host of Comprehensive Clinical Services
Since opening in 2001, the UC Health Pancreatic Disease Center has become a leader in the treatment of pancreatic diseases, including chronic pancreatitis and pancreatic cancer. The multidisciplinary team treats several hundred patients annually from across the United States.
The UC Health Pancreatic Disease Center offers clinical consultations by appointment. We welcome both inpatient and outpatient referrals. Located in the heart of the University of Cincinnati Medical campus at the UC Barrett Cancer Center, the UC Health Pancreatic Disease Center delivers a full host of services for patients with pancreatic disorders:
- Endoscopic Ultrasound (EUS) with biopsy capabilities
- Diagnostic and Therapeutic Endoscopic Retrograde Cholangiopancreatography (ERCP)
- Noninvasive imaging of the pancreas
- State-of-the-art surgical management of benign and malignant pancreatic diseases
- Autologous Islet cell transplantation
- Comprehensive CLIA laboratory
The UC Health Pancreatic Disease Center offers clinical consultations for patients by appointment. We welcome both inpatient and outpatient referrals. Patients are welcomed to schedule appointments without a physician referral.
To schedule your first appointment, call (513) 584-0437.
Islet Cell Transplantation Gives Hope to Patients with Pancreatitis
UC Health is one of only a few major centers in the United States that offer pancreatectomy (removal of the pancreas) with autologous islet cell transplant to treat chronic pancreatitis (inflammation of the pancreas). UC Health began offering the procedure in 1999. Performed when removal of the pancreas is the best option, autologous islet cell transplantation allows a patient to be treated for the pain of pancreatitis without the serious debilitating side effects of a total pancreatectomy.
Patients express a dramatic improvement in their quality of life after the transplant, and a great majority of patients that had previously been on narcotics to control abdominal pain are able to be weaned off of all pain medications. In addition, our most recent analysis demonstrates that approximately 40% of patients do not require any insulin after surgery.